Theorem Clinical Research

CROs/Service Providers

Cromsource expands European headquarters, opens new office

Wednesday, April 16, 2014 01:26 PM

International CRO Cromsource has opened a new office in Verona, Italy. The building expands its European headquarters.

More... »


Arsenal Capital acquires Synchrogenix for regulatory writing, submission services, will merge it with Certara

Tuesday, April 15, 2014 01:11 PM

By Ronald Rosenberg
CenterWatch Staff Writer

Arsenal Capital Partners, a private equity firm that acquired software and scientific consulting services provider Certara last December, now has purchased Synchrogenix, an independent regulatory-writing CRO, and will merge the two.

More... »


Catalent, Zhejiang Hisun Pharma to collaborate on biosimilar development

Monday, April 14, 2014 03:05 PM

Catalent Pharma Solutions, a global provider of development solutions and advanced delivery technologies for drug, biologic and consumer health products, has signed an agreement with Zhejiang HISUN Pharmaceuticals to provide HISUN with a broad range of biosimilar cell lines, using Catalent's proprietary GPEx technology for the Chinese market. The development and manufacturing programs will benefit from the GPEx technology's proven capability to produce very stable and high-yielding cell lines.

More... »

Study: Merit increase budgets rising in global CRO industry

Friday, April 11, 2014 12:04 PM

A recent survey conducted by HR+Survey Solutions, a compensation consulting and research firm, found merit increase budgets are on the rise in the global CRO industry. The 2013-2014 CRO Industry Global Salary Planning Survey found while the highest reported salary increase budget across the globe for 2013 was 21%, that figure rose to 25% for 2014. The country with the highest average budgeted increase is Argentina, with an average increase of 16.1% for 2014. The country with the lowest average budget increase is Portugal, with an average increase budget of only 1.8%. This compares to the overall global average budgeted increase for 2014 of 4.1%.

More... »

Karyopharm Therapeutics enters agreement with Clinipace Worldwide

Thursday, April 10, 2014 01:49 PM

Clinipace Worldwide, a global digital CRO (dCRO), has announced that Karyopharm Therapeutics, a clinical-stage pharmaceutical company focused on the discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases, has entered into a preferred provider agreement with Clinipace to manage several clinical programs, including oncology and wound healing.

More... »

Evotec inks agreements with Debiopharm Group, Convergence

Monday, April 7, 2014 12:37 PM

Evotec, a drug discovery alliance and development partnership company, has formed a research collaboration and licensing deal with Debiopharm Group, a Swiss-based global biopharmaceutical group, to identify and develop novel compounds having the potential to treat multiple forms of solid tumors and leukemias with defined genetic alterations.

More... »

WuXi PharmaTech invests in TruTag security platform for drug safety

Monday, April 7, 2014 12:36 PM

CRO WuXi PharmaTech, with operations in China and the U.S., and TruTag Technologies, developer of an edible, covert security platform to address the global product counterfeiting challenge, have announced that WuXi Corporate Venture Fund has made an investment in TruTag.

More... »

CTI Clinical Trial and Consulting Services to open new office

Thursday, April 3, 2014 10:58 AM

CTI Clinical Trial and Consulting Services, a global, privately held, full-service CRO, will relocate the company’s Consulting and Health Economics and Outcomes Research (HECOR) divisions to University Station adjacent to the Xavier University campus in Cincinnati, Ohio.

More... »

CROnos Clinical Consulting to launch E-learning platform

Wednesday, April 2, 2014 01:59 PM

CROnos Clinical Consulting, a global provider of centralized risk-based data monitoring and data visualization solutions for neuroscience clinical trials, is launching an e-learning and mobile platform that will enable sponsors to transmit clinical knowledge to sites and study teams.

More... »

Annalisa Jenkins named IIR Partnerships’ Woman of the Year

Tuesday, April 1, 2014 01:43 PM

Annalisa Jenkins, former executive vice president, head of global R&D at Merck Serono, has been named IIR Partnerships’ Woman of the Year.

More... »

Subscribe to The CenterWatch Monthly
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

October 13

First Sunshine Act data posted online; many cite errors, lack of context to help consumers understand payments

In appreciation: Felix Gyi will be remembered for his passion, leadership and desire to educate, pay it forward

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Today's fastest, most economical sponsors
Standout sponsors reveal how they shorten regulatory, clinical cycle times

From the trenches: Sites' eye view of state of the industry
CW’s first site focus groups uncover frustration with 'progress,' but a passion for their mission

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs